JOUNCE THERAPEUTICS INC's ticker is and the CUSIP is 481116901. A total of 3 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4 | – | 2,200 | +144.4% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 900 | -52.6% | 0.00% | – |
| Q3 2022 | $4,000 | – | 1,900 | +850.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 200 | -93.9% | 0.00% | – |
| Q1 2022 | $22,000 | -29.0% | 3,300 | -13.2% | 0.00% | – |
| Q4 2021 | $31,000 | +416.7% | 3,800 | +280.0% | 0.00% | – |
| Q3 2021 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | – | 1,000 | +930.9% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 97 | -43.3% | 0.00% | – |
| Q4 2020 | $119,000 | +170.5% | 171 | +216.7% | 0.00% | – |
| Q3 2020 | $44,000 | -59.3% | 54 | -65.6% | 0.00% | – |
| Q2 2020 | $108,000 | -10.0% | 157 | -37.9% | 0.00% | – |
| Q1 2020 | $120,000 | +14.3% | 253 | +109.1% | 0.00% | – |
| Q4 2019 | $105,000 | +400.0% | 121 | +86.2% | 0.00% | – |
| Q3 2019 | $21,000 | -70.4% | 65 | -44.0% | 0.00% | – |
| Q1 2019 | $71,000 | +373.3% | 116 | +146.8% | 0.00% | – |
| Q4 2018 | $15,000 | +87.5% | 47 | +261.5% | 0.00% | – |
| Q3 2018 | $8,000 | -84.6% | 13 | -81.2% | 0.00% | – |
| Q2 2018 | $52,000 | +30.0% | 69 | -63.9% | 0.00% | -100.0% |
| Q1 2018 | $40,000 | – | 191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|